News Daily News POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies L.A. McKeown July 15, 2025
News Daily News Brachytherapy Remains an Option for DES In-Stent Restenosis Yael L. Maxwell January 12, 2023
News Daily News New Biomarker-Based Risk Score Performs Well in ACS Michael O'Riordan October 25, 2022
News Daily News IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document L.A. McKeown August 05, 2022
News Daily News DCB in Diabetes Show Promising Long-term Outcomes: BASKET-SMALL 2 L.A. McKeown August 16, 2021
News Daily News Tocilizumab Improves Myocardial Salvage After STEMI: ASSAIL-MI Michael O'Riordan April 12, 2021
News Daily News No Harm, No Help With Bioabsorbable-Polymer Stents: Registry Michael O'Riordan March 01, 2021
News Daily News Thrombus Burden Greater in STEMI Patients With COVID-19 Michael O'Riordan July 20, 2020
News Daily News Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5 Michael O'Riordan July 07, 2020
News Daily News Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis Michael O'Riordan February 10, 2020
News Daily News Recurrent Events Common Among Young Patients With CAD Michael O'Riordan October 11, 2019
News Daily News TCT 2019 BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On L.A. McKeown October 02, 2019
News Daily News Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure? Yael L. Maxwell May 15, 2019
News Daily News Ultrathin-Strut DES Outperform Second-Gen DES at 1 Year: Meta-analysis Caitlin E. Cox June 28, 2018
News Daily News Platelet Reactivity Linked With Ischemic Stroke Risk Post-DES Implantation: ADAPT-DES Substudy Yael L. Maxwell June 08, 2018
News Daily News ADAPT-DES at 2 Years Offers Insights Into Provider Strategies and Aspirin Monotherapy Beyond 1 Year Yael L. Maxwell August 07, 2017
News Daily News Cobra Stent With Ultrathin Polymer Safe, Effective but Needs Testing in Tougher Patients Michael O'Riordan February 03, 2017
News Daily News Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds? Michael O'Riordan February 02, 2017
News Daily News Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis Michael O'Riordan April 25, 2016